Pharmaceuticals, Biotechnology and Life Sciences
BASEL, Switzerland and LONDON and NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) — Great Place To Work® and Fortune magazine…
TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone”…
NEW YORK and WALTHAM, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company…
BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a…
CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),…
Company announcement – No. 20 / 2025 Zealand Pharma increases its share capital as a result of the exercise of…
SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — Recludix Pharma, a leader in the discovery of inhibitors of challenging targets…
OSE Immunotherapeutics and the FoRT Foundation Announce Completion of Enrollment in Combi-TED, a Phase 2 Clinical Trial Evaluating Tedopi® in…
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article…
Topline data from pivotal Phase 3 Iocyte AMI-3 trial expected in Q4 2025SEATTLE, Sept. 11, 2025 (GLOBE NEWSWIRE) — Faraday…